// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

National cohort study on fetal reduction in dichorionic twin pregnancies: risks and pregnancy outcome

S.E. Kristensen - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Role of prenatal magnetic resonance imaging in fetuses with isolated severe ventriculomegaly in the era of neurosonography: a multicentre study

D. Di Mascio - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hydrocephalus, congenital, 1

N/A

Incidence and patterns of abnormal corpus callosum in fetuses with spina bifida: a cross-sectional study in two fetal surgery centres

Y. Kunpalin - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Spina bifida

N/A

Cortical surface matching of the fetal cortex pre- and post-fetal surgery for open spina bifida

N. Mufti - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Spina bifida

N/A

Cranial findings detected by second trimester ultrasound in fetuses with spina bifida aperta: a systematic review

Y. Kunpalin - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Spina bifida

N/A

What brain abnormalities can magnetic resonance imaging detect in fetal and early neonatal spina bifida: a systematic review

N. Mufti - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Spina bifida

N/A

Management of Noonan syndrome in pregnancy

K. Singhal - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Uptake of prenatal testing in a case series of liveTbirths with Trisomy 21

K. Odubamowo - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Down syndrome

N/A

Birth outcomes of babies with Trisomy 21

A. Kaelin Agten - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Down syndrome

N/A

The diagnostic yield of prenatal genomic testing in congenital heart defects: a cohort study

F. Mone - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Perinatal and genetic outcomes in anomalous fetuses of consanguineous union: a cohort study

F. Mone - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Non-immune hydrops fetalis and diagnostic yield with prenatal-exome sequencing: a case series

F. Mone - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Dimensionless jerk: an objective differential to assess experienced and novice ultrasound operators in a clinical setting

B. Dromey - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Use of the focus point for plane acquisition to improve reproducibility in fetal biometry

S. Vignola - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Long-term evaluation of retention of acquired ultrasound theoretical knowledge and skills following an intensive ISUOG ultrasound course in the Sultanate of Oman

N. Vrachnis - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Machine learning algorithms in ultrasound: quality assurance metrics for annotations used in training

A. Self - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Attainment rates of trainee competence in different biometric parameters during a practical ultrasound training course: is there a difference?

E. Enabudoso - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Machine learning of the basic obstetric ultrasound examination: validation of the standardised six-step approach

A. Self - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Training in fetal biometry: a prospective reproducibility study

M. Stegen - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Qualitative assessment of the feasibility and acceptability of a low-cost device for gestational age assessment in a low-resource setting

A.K. Etyang - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved